The effects of different therapeutic modalities on cardiovascular risk factors in women with polycyst ıc ovary syndrome: A randomızed controlled study

This study was designed to evaluate the effects of 3  mg drospirenone/30 μg ethinyl estradiol (OC) alone or combined with 1700 mg metformin on metabolic risk factors.
Source: Taiwanese Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Original Article Source Type: research